Skip to main content
. Author manuscript; available in PMC: 2014 Aug 17.
Published in final edited form as: Cancer Biol Ther. 2007 Jul 24;6(10):1632–1637. doi: 10.4161/cbt.6.10.4790

Figure 1.

Figure 1

Chemical structures of ledakrin, C-1748, (9(2′-hydroxy-ethylamino)-4-methyl-1-nitroacridine) and C-1748 analogs are represented as C-1860 (9(2′-propionoxyethylamino)-4-methyl-1-nitroacridine), C-1872 (9(3′-acetoxypropylamino)-4-methyl-1-nitroacridine), C-1873 (9(3′-propionoxypropylamino)-4-methyl-1-nitroacridine).